Close

Analyst Ratings for Protalix BioTherapeutics (PLX) [Neutrals]

PLX Rating Summary

PLX Price Target Summary

* Over Last 12-Mos
  |   Expand Research on PLX
Overall Rating: NEUTRAL   Rating Trend: =   Avg. $ Target: $10.00 (+726.4%) * Over Last 12-Mos
Rating Score: 3.8 / 10   Percentile Rank: 36%
Date Firm Analyst Type Rating
(Past)
PT
(Past)
Start $
(End $)
% Chg. Details
6/25/2012 Wells Fargo N/A Downgrade Equal Weight
(Overweight)
N/A
(N/A)
6.19
(1.21)
-80.45% Details
6/12/2012 Aegis Capital N/A New Coverage Hold
(N/A)
N/A
(N/A)
6.65
(1.21)
-81.8% Details